Informa plc (LON:INF - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 836.12 and traded as high as GBX 890.80. Informa shares last traded at GBX 888.40, with a volume of 1,887,173 shares trading hands.
Analysts Set New Price Targets
INF has been the topic of a number of research reports. Berenberg Bank raised their price target on Informa from GBX 965 to GBX 1,040 and gave the stock a "buy" rating in a research note on Friday, July 31st. Citigroup upped their price objective on Informa from GBX 990 to GBX 1,090 and gave the company a "buy" rating in a research report on Wednesday, August 12th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 1,140 target price on shares of Informa in a report on Friday, July 31st. Finally, JPMorgan Chase & Co. dropped their target price on Informa from GBX 1,300 to GBX 1,285 and set an "overweight" rating on the stock in a research report on Thursday, July 2nd. Six research analysts have rated the stock with a Buy rating, According to MarketBeat, Informa currently has an average rating of "Buy" and a consensus target price of GBX 1,135.
Read Our Latest Research Report on Informa
Informa Trading Down 1.4%
The firm has a market capitalization of £11.10 billion, a PE ratio of 51.95, a PEG ratio of 0.75 and a beta of 0.68. The company has a quick ratio of 1.70, a current ratio of 0.55 and a debt-to-equity ratio of 64.99. The stock's fifty day simple moving average is GBX 898.38 and its 200 day simple moving average is GBX 836.12.
Informa (LON:INF - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. On average, sell-side analysts predict that Informa plc will post 59.3240265 earnings per share for the current year.
Informa Company Profile
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.